Calamos Advisors
DTRT

Calamos Advisors’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Calamos Advisors’s Portfolio DTRT Stock Details DTRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300,000
Closed -$3.05M – 1462
2022
Q3 		$3.05M Buy
+300,000
New +$3.03M 0.01% 792

Other funds holding DTRT

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Calamos Advisors's DTRT Position: Q4 2022 in Review

Calamos Advisors sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 300,000 shares — an estimated $3.05M sold.

Calamos Advisors first reported a position in DTRT in Q3 2022 and held it in 1 quarter. The position peaked at $3.05M in Q3 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.

  • Calamos Advisors reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Calamos Advisors sold 300,000 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $3.05M.
  • Calamos Advisors first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Calamos Advisors's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $3.05M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.